0001209191-16-108960.txt : 20160316 0001209191-16-108960.hdr.sgml : 20160316 20160316201531 ACCESSION NUMBER: 0001209191-16-108960 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160314 FILED AS OF DATE: 20160316 DATE AS OF CHANGE: 20160316 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sarepta Therapeutics, Inc. CENTRAL INDEX KEY: 0000873303 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 930797222 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 415 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-274-4000 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 415 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Sarepta Therapuetics, Inc. DATE OF NAME CHANGE: 20120712 FORMER COMPANY: FORMER CONFORMED NAME: AVI BIOPHARMA INC DATE OF NAME CHANGE: 19980930 FORMER COMPANY: FORMER CONFORMED NAME: ANTIVIRALS INC DATE OF NAME CHANGE: 19970123 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BEHRENS M KATHLEEN CENTRAL INDEX KEY: 0001211701 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14895 FILM NUMBER: 161511004 MAIL ADDRESS: STREET 1: 6701 KAISER DRIVE CITY: FREMONT STATE: CA ZIP: 94555 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-03-14 0 0000873303 Sarepta Therapeutics, Inc. SRPT 0001211701 BEHRENS M KATHLEEN 215 FIRST STREET, SUITE 415 CAMBRIDGE MA 02142 1 0 0 0 Common Stock 2016-03-14 4 P 0 65000 16.5427 A 112166 D Common Stock 2016-03-16 4 P 0 10000 14.5433 A 21855 I By Trust The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $16.18 to $17.10, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.51 to $14.55, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. /s/ David Tyronne Howton 2016-03-16